Hinge Health posts FY 2025 net loss of USD 528.3 million

Reuters03-04
<a href="https://laohu8.com/S/HNGE">Hinge Health</a> posts FY 2025 net loss of USD 528.3 million

Hinge Health reported FY 2025 revenue of USD 587.9 million, up 51% year over year, with gross profit of USD 468.2 million (gross margin: 80%). Net loss for FY 2025 was USD 528.3 million, and loss from operations was USD 546.4 million; results included USD 643.0 million of stock-based compensation expense, primarily tied to the satisfaction of vesting criteria achieved with the company’s May 2025 IPO. On a non-GAAP basis, Hinge Health posted operating income of USD 119.5 million (non-GAAP operating margin: 20%). Net cash provided by operating activities was USD 171.4 million and free cash flow was USD 179.6 million (free cash flow margin: 31%). Business updates for FY 2025 included the launch of HingeSelect, its in-person provider network for MSK care, and continued scaling of its AI-powered TrueMotion motion-tracking delivery model. The company ended 2025 with 2,830 clients, about 25 million contracted lives, and 782,890 members; 12-month client retention was 97%. Hinge Health also said it completed its IPO in May 2025, generating USD 255.7 million in net proceeds (before offering expenses payable by the company), which it used substantially to pay employee taxes related to RSU and PRSU settlements. In addition, the board approved a USD 250.0 million share repurchase program in November 2025; by year-end, USD 65.0 million had been deployed to repurchase 1,384,485 Class A shares, leaving about USD 185.0 million authorized.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hinge Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-013808), on March 03, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment